Document is current
Any future updates will be listed below
-
Authors
Gold, L. S.
Cody, R. F. Jr.
Tan, W. K.
Marcum, Z. A.
Meier, E. N.
Sherman, K. J.
James, K. T.
Griffith, B.
Avins, A. L.
Kallmes, D. F.
Suri, P.
Friedly, J. L.
Heagerty, P. J.
Deyo, R. A.
Luetmer, P. H.
Rundell, S. D.
Haynor, D. R.
Jarvik, J. G.
-
Funding
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (U24AT009676)
National Institutes of Health (UH2AT007766, UH3AR066795, P30AR072572)
- License Information
-
More Information
Article History
Received: 2 February 2022
Accepted: 22 May 2022
First Online: 3 June 2022
Declarations
:
: All participating institutional review boards determined that the study was minimal risk and granted waivers of both consent and Health Insurance Portability and Accountability Act authorization. All procedures performed in studies involving human participants were performed in accordance with the ethical standards of the institutional committees and with the 1964 Declaration of Helsinki and its later amendments.
: David F. Kallmes discloses that he has ownership/stock in Kypheze, LLC; patents involved in spine augmentation; and has received research support and royalties from Medtronic. Laura S. Gold, Richard F. Cody, Jr., W. Katherine Tan, Zachary A. Marcum, Eric N. Meier, Karen J. Sherman, Kathryn T. James, Brent Griffith, Andrew L. Avins, Pradeep Suri, Janna L. Friedly, Patrick J. Heagerty, Richard A. Deyo, Patrick H. Luetmer, Sean D. Rundell, David R. Haynor, and Jeffrey G. Jarvik do not have financial or non-financial interests that are directly or indirectly related to this work.
